2m 2m 2m 2m 2m 2m 2m
Collegium Pharma (COLL)
NASDAQ
$34.61-$0.02 (-0.04%)
Price as of Jun 23, 2026 4:25 PM EDT- $1.1BMarket Cap
- 11.95%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Collegium Pharma (COLL)
$34.61-$0.02 (-0.04%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK INC. | 17.86% | 5.8M | -72,516 (-1.25%) | Jun 30, 2024 |
BLACKROCK FUNDING, INC. /DE | 17.13% | 5.6M | +35,784 (+0.64%) | Dec 31, 2024 |
BLACKROCK, INC. | 15.83% | 5.1M | +34,325 (+0.67%) | Mar 31, 2026 |
VANGUARD GROUP INC | 6.96% | 2.3M | +29,876 (+1.32%) | Dec 31, 2025 |
JANUS HENDERSON GROUP PLC | 5.63% | 1.8M | +377,073 (+20.65%) | Mar 31, 2026 |
INVESCO LTD. | 4.91% | 1.6M | +416,868 (+26.19%) | Mar 31, 2026 |
FULLER & THALER ASSET MANAGEMENT, INC. | 4.62% | 1.5M | -488 (-0.03%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
iSHARES TRUST | 10.53% | 3.4M | +39 (+0.001%) | Mar 31, 2026 |
ELLSWORTH GROWTH & INCOME FUND LTD | 4.62% | 1.5M | 0 (0.00%) | Mar 31, 2026 |
Capitol Series Trust | 4.41% | 1.4M | 0 (0.00%) | Mar 31, 2026 |
AMERICAN BEACON FUNDS | 4.38% | 1.4M | 0 (0.00%) | Jan 31, 2026 |
MUTUAL FUND SERIES TRUST | 4.34% | 1.4M | -453,500 (-32.21%) | Mar 31, 2026 |
VANGUARD INDEX FUNDS | 4.01% | 1.3M | +26,804 (+2.06%) | Mar 31, 2026 |
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 3.08% | 1.0M | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions690.2M (68.21%)
- Mutual Funds310.4M (30.67%)
- Insiders11.3M (1.11%)
- Other0 (0.00%)
Insider Transactions
- 1.11% (11.3M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 8Number of InsiderSelling (last 12 months)
- $150.5MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Dieter David EVP & General Counsel | Sell | Mar 18, 2026 | $488,099.22 | 13,976 | $34.92 | 77,071 |
Dieter David EVP & General Counsel | In Kind | Mar 17, 2026 | $315,764.80 | 8,840 | $35.72 | 68,231 |
Dieter David EVP & General Counsel | Sell | Mar 09, 2026 | $228,109.60 | 6,224 | $36.65 | 91,047 |
Dreyer Scott EVP & Chief Commercial Officer | Sell | Mar 03, 2026 | $1.9M | 46,417 | $40.36 | 75,329 |
Dreyer Scott EVP & Chief Commercial Officer | Sell | Mar 03, 2026 | $145,879.50 | 3,559 | $40.99 | 71,770 |
Dieter David EVP & General Counsel | Award | Feb 10, 2026 | $0.00 | 22,194 | $0.00 | 91,047 |
Karnani Vikram President and CEO | Award | Feb 10, 2026 | $0.00 | 79,264 | $0.00 | 176,629 |
Dreyer Scott EVP & Chief Commercial Officer | Award | Feb 10, 2026 | $0.00 | 19,023 | $0.00 | 122,636 |
Smith Thomas B EVP and Chief Medical Officer | Award | Feb 10, 2026 | $0.00 | 14,268 | $0.00 | 85,312 |
Dieter David EVP & General Counsel | Award | Feb 10, 2026 | $0.00 | 9,005 | $0.00 | 100,052 |
Karnani Vikram President and CEO | Award | Feb 10, 2026 | $0.00 | 32,531 | $0.00 | 209,160 |
Tupper Colleen EVP & Chief Financial Officer | Award | Feb 10, 2026 | $0.00 | 26,421 | $0.00 | 153,088 |
Smith Thomas B EVP and Chief Medical Officer | Award | Feb 10, 2026 | $0.00 | 22,774 | $0.00 | 108,086 |
Dieter David EVP & General Counsel | In Kind | Feb 10, 2026 | $130,011.75 | 2,781 | $46.75 | 97,271 |
Karnani Vikram President and CEO | In Kind | Feb 10, 2026 | $528,088.00 | 11,296 | $46.75 | 197,864 |
Dreyer Scott EVP & Chief Commercial Officer | Award | Feb 10, 2026 | $0.00 | 30,702 | $0.00 | 153,338 |
Smith Thomas B EVP and Chief Medical Officer | In Kind | Feb 10, 2026 | $275,684.75 | 5,897 | $46.75 | 102,189 |
Tupper Colleen EVP & Chief Financial Officer | Award | Feb 10, 2026 | $0.00 | 32,734 | $0.00 | 185,822 |
Smith Thomas B EVP and Chief Medical Officer | In Kind | Feb 10, 2026 | $539,401.50 | 11,538 | $46.75 | 90,651 |
Dreyer Scott EVP & Chief Commercial Officer | In Kind | Feb 10, 2026 | $466,424.75 | 9,977 | $46.75 | 143,361 |
Tupper Colleen EVP & Chief Financial Officer | In Kind | Feb 10, 2026 | $554,501.75 | 11,861 | $46.75 | 173,961 |
Dreyer Scott EVP & Chief Commercial Officer | In Kind | Feb 10, 2026 | $1.0M | 21,615 | $46.75 | 121,746 |
Tupper Colleen EVP & Chief Financial Officer | In Kind | Feb 10, 2026 | $1.2M | 26,679 | $46.75 | 147,282 |
Karnani Vikram President and CEO | In Kind | Nov 12, 2025 | $425,345.05 | 8,983 | $47.35 | 96,989 |
Fallon John A. | Exempt | Nov 12, 2025 | $0.00 | 15,000 | $0.00 | 0 |
Fallon John A. | Exempt | Nov 12, 2025 | $0.00 | 19,853 | $0.00 | 0 |
Fallon John A. | Exempt | Nov 12, 2025 | $247,350.00 | 15,000 | $16.49 | 79,634 |
Fallon John A. | Exempt | Nov 12, 2025 | $185,228.49 | 19,853 | $9.33 | 99,487 |
Fallon John A. | Sell | Nov 12, 2025 | $1.6M | 34,853 | $47.21 | 64,634 |
Tupper Colleen EVP & Chief Financial Officer | Sell | Nov 06, 2025 | $1.0M | 25,142 | $40.38 | 131,525 |